Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma

Carcinogenesis

Volumn 23, Issue 1, 2002, Pages 25-33

  Kamiya, Yuji ^a   Puzianowska Kuznicka, Monika ^c,d   McPhie, Peter ^b   Nauman, Janusz ^c   Cheng, Sheue Yann ^a   Nauman, Alicja ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; LIOTHYRONINE; MESSENGER RNA; RECEPTOR SUBUNIT; THYROID HORMONE RECEPTOR;

ALPHA CHAIN; ARTICLE; BETA CHAIN; BINDING SITE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSCRIPTION AND TRANSLATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; MOLECULAR CLONING; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036200861     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.1.25     Document Type: Article

References (59)

1. Renal, perirenal and ureteral neoplasms
2. Mutations of the VHL tumour suppressor gene in renal carcinoma
3. Inactivaction of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis
4. Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus
5. Absence or reduction of Fhit expression in most clear cell renal carcinomas
6. The genetic locus NRC-1 within chromosome 2p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment and VHL mutation
7. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis
8. Involvement of multiple loci on chromosome 3 in renal cell cancer development
9. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development
10. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors
11. Both thyroid hormone and 9-cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis
12. Nuclear receptor coregulators: Cellular and molecular biology
13. Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctioning tumors of the anterior pituitary
14. Thyroid receptor alpha 1 and alpha 2 mutations in nonfunctioning pituitary tumors
15. Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: Interactions among T3, vitamin D3 and retinoid signalling
16. Stimulation of proliferation by 3,3′,5-triiodo-L-thyronine in poorly differentiated human hepatocarcinoma cells overexpressing β1 thyroid hormone receptor
17. Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells
18. Thyroid hormone and neoplastic transformation
19. erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma
20. Localization of human ERBA2 to the 3p22-3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer
21. (186) Chromosomal localization of the human oncogene ERBA2
22. Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers
23. Loss of heterozygosity of the thyroid hormone receptor β in posterior uveal melanoma
24. Presence of two members of c-erbA receptor gene family (c-erbA and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma
25. Molecular genetic investigation of sporadic renal cell carcinoma: Analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22
26. Lack of loss of heterozygosity at the c-erb A beta locus in gastrointestinal tumors
27. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms
28. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer
29. Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma
30. The differential hormone-dependent transcriptional activity of thyroid hormone receptor isoforms is mediated by interplay of their domains
31. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction
32. Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differentially modified by 9-cis retinoic acid
33. The structure of the carboxyl-terminal region of thyroid hormone nuclear receptor and its role in hormone-dependent intermolecular interactions
34. Intracellular distribution of the endogenous and transfected β form of thyroid hormone nuclear receptor visualized by the use of domain-specific monoclonal antibodies
35. Resistance to thyroid hormone
36. The c-erb-A gene encodes a thyroid hormone receptor
37. The c-erb-A protein is a high affinity receptor for thyroid hormone
38. Leukemic transformation by the v-erbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo
39. The v-erbA oncogene
40. Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA
41. Additivity of mutational effects in proteins
42. A structural role for hormone in the thyroid hormone receptor
43. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma
44. Identification of naturally occuring dominant negative mutants of thyroid hormone alpha1 and beta1 receptors in a human hepatocellular carcinoma cell line
45. Retinoid X receptor and c-erbA/thyroid hormone receptor regulate erythroid cell growth and differenitation
46. Thyroid hormone inhibits growth and stimulates terminal differentiation of epiphyseal growth plate chondrocytes
47. Regulation of vertebrate muscle differentiation by thyroid hormone: The role of the myoD gene family
48. Thyroid hormone induces apoptosis in primary cell cultures of tadpole intestine: Cell type specificity and effects of extracellular matrix
49. Effects of thyroid hormones on apoptotic cell death of human lymphocytes
50. T3 treatment increases mitosis, then bax expression and apoptosis in the optic lobe of the chick embryo
51. Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53
52. Tumor suppressor p53 is a negative regulator in thyroid hormone receptor pathways
53. Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site
54. Repression of c-fos gene by thyroid hormone and retinoic acid receptors
55. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities
56. Mdm2 promotes rapid degradation of p53
57. Regulation of the mdm2 oncogene by thyroid hormone receptor
58. p53 from complexity to simplicity: Mutant p53 stabilization, gain-of-function and dominant-negative effect